← back to search

Helen Michael

IDEXX Laboratories (United States) · US
Area of research
Reproductive Medicine · Surgery
Research interest
Research interests include Ovarian cancer diagnosis and treatment, Testicular diseases and treatments, Sarcoma Diagnosis and Treatment, and Endometrial and Cervical Cancer Treatments.
h-index
37
citations
5,581
works
108
NIH funding
primary concept
email

Recent publications

Weekly biological variation of serum biochemistry analytes and fibroblast growth factor 23 in healthy cats and cats with chronic kidney disease.
2025cited by 0position: contributordoi
Blood fibroblast growth factor 23 concentration in cats with and without chronic kidney disease: a scoping review.
2024cited by 3position: contributordoi
PTEN phosphatase inhibits metastasis by negatively regulating the Entpd5/IGF1R pathway through ATF6
iScience 2023cited by 16position: middledoi
Cat Friendly Practice improves feline visits, resulting in increased laboratory testing and increased diagnosis of certain common feline conditions.
2023cited by 3position: contributordoi
Seropositivity of main vector-borne pathogens in dogs across Europe.
2022cited by 29position: contributordoi
Improving quality control for in-clinic hematology analyzers: Common myths and opportunities.
2022cited by 1position: contributordoi
Frequency of respiratory pathogens and SARS-CoV-2 in canine and feline samples submitted for respiratory testing in early 2020.
2021cited by 21position: contributordoi
A UVB-responsive common variant at chromosome band 7p21.1 confers tanning response and melanoma risk via regulation of the aryl hydrocarbon receptor, AHR.
2021cited by 17position: contributordoi
Longitudinal evaluation of symmetric dimethylarginine and concordance of kidney biomarkers in cats and dogs.
2021cited by 15position: contributordoi
A longitudinal study of the persistence of increased creatinine and concordance between kidney biomarkers in cats and dogs.
2021cited by 6position: contributordoi
Multimodel preclinical platform predicts clinical response of melanoma to immunotherapy
Nature Medicine 2020cited by 117position: middledoi
Melanoblast transcriptome analysis reveals pathways promoting melanoma metastasis.
2020cited by 85position: contributordoi
A direct link between MITF, innate immunity, and hair graying
PLoS Biology 2018cited by 78position: middledoi
Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer
New England Journal of Medicine 2016cited by 365position: middledoi
Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology–Gynecologic Oncology Group protocol 240)
The Lancet Oncology 2015cited by 149position: middledoi
Randomized Phase III Trial of Gemcitabine Plus Docetaxel Plus Bevacizumab or Placebo As First-Line Treatment for Metastatic Uterine Leiomyosarcoma: An NRG Oncology/Gynecologic Oncology Group Study
Journal of Clinical Oncology 2015cited by 124position: lastdoi
Sporadic naturally occurring melanoma in dogs as a preclinical model for human melanoma
Pigment Cell & Melanoma Research 2013cited by 160position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Glenn Merlino · National Institutes of Health3 papers (2018–2023)David M. O’Malley · Bexley Hall2 papers (2015–2016)Helen Huang · University at Buffalo, State University of New York2 papers (2015–2016)Richard T. Penson · Harvard University2 papers (2015–2016)Chi‐Ping Day · National Institutes of Health2 papers (2018–2020)Bradley J. Monk · University of Cincinnati Medical Center2 papers (2015–2016)Derek Gildea · National Human Genome Research Institute1 papers (2018–2018)Thomas Reid · Roswell Park Comprehensive Cancer Center1 papers (2015–2015)Roger S. Lo · University of California, Los Angeles1 papers (2020–2020)Suman K. Vodnala · Lyell Immunopharma (United States)1 papers (2020–2020)John K. Chan · Sutter Health1 papers (2016–2016)Miriam R. Anver · Eunice Kennedy Shriver National Institute of Child Health and Human Development1 papers (2013–2013)Anyen Fon · Center for Cancer Research1 papers (2020–2020)Michael Method · KU Leuven1 papers (2015–2015)Donald J. Meuten · North Carolina State University1 papers (2013–2013)Jamie N. Bakkum‐Gamez · Mayo Clinic1 papers (2015–2015)Willy Hugo · APLA Health1 papers (2020–2020)Martee L. Hensley · Memorial Sloan Kettering Cancer Center1 papers (2015–2015)Paul DiSilvestro · AstraZeneca (Italy)1 papers (2016–2016)Terry Van Dyke · Center for Cancer Research1 papers (2020–2020)